Delivery Order SPE2DB25D3003-SPE2DB26FPVFU
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,922.90 firm fixed-price delivery order for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of November 6, 2025. This competitively awarded contract, issued on November 5, 2025, represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where...
- The Defense Logistics Agency awarded a delivery order valued at $2,603.55 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of August 4, 2025. This non-competitive delivery order represents a firm fixed-price transaction executed on August 1, 2025, with the product to be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Repatha is a prescription medication used to lower cholesterol levels and...
- The Defense Logistics Agency awarded a $22,521.04 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of October 31, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger contract vehicle with DLA. This delivery order falls under...
- The Defense Logistics Agency awarded a $5,536.88 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors under a firm fixed price contract. The award was made on September 26, 2025, with an ultimate completion date of September 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, demonstrating AmerisourceBergen's continued capability to meet federal...
- The Defense Logistics Agency awarded a $6,884.63 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of July 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply relationship with the...
- The Defense Logistics Agency awarded a delivery order valued at $7,949.53 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of October 23, 2025. This non-competitive, firm fixed-price delivery order was issued on October 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Repatha is a PCSK9 inhibitor used for cholesterol management in patients with cardiovascular disease,...
- The Defense Logistics Agency awarded a delivery order valued at $13,775.33 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, issued on October 22, 2025, represents a competitive award with no set-aside designation and is scheduled for completion by October 23, 2025. The pharmaceutical product will be sourced and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as...
- The Defense Logistics Agency awarded a delivery order valued at $6,004.71 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of August 4, 2025. The contract was awarded on August 1, 2025, using firm fixed pricing with no set-aside designation, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitive award to a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,041.42 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with a completion date of July 23, 2025. This non-competitive, firm fixed-price delivery order was issued on July 22, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Repatha is a prescription medication used to treat high cholesterol and reduce the risk of cardiovascular disease. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,915.78 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pens, with an ultimate completion date of November 6, 2025. This firm fixed price delivery order, awarded on November 5, 2025, represents a non-competitive procurement executed under an existing contract vehicle. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- SPE2DB25D3003Indefinite Delivery Contract
- SPE2DB25D3003-SPE2DB26FPVFUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,948.71 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of November 5, 2025. This non-competitive, firm fixed-price delivery order was issued on November 4, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive pharmaceutical support mechanism enabling the company to supply brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare programs globally. Repatha is a cardiovascular medication used for cholesterol management, reflecting the breadth of therapeutic domains covered under the IDC framework. AmerisourceBergen's position as a prime pharmaceutical vendor demonstrates its capability to meet federal procurement requirements for critical medical commodities supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 11/4/25 |